Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Debt to Equity Ratio : 0.9865 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9865 |
| March 31, 2026 | 1.062 |
| December 31, 2025 | 1.023 |
| September 30, 2025 | 0.788 |
| June 30, 2025 | 0.5948 |
| March 31, 2025 | 13.21 |
| December 31, 2024 | 4.605 |
| September 30, 2024 | 2.407 |
| June 30, 2024 | 35.53 |
| March 31, 2024 | -2.949 |
| December 31, 2023 | -4.104 |
| September 30, 2023 | -4.679 |
| June 30, 2023 | -8.622 |
| March 31, 2023 | -29.95 |
| December 31, 2022 | 15.10 |
| September 30, 2022 | -27.70 |
| June 30, 2022 | 18.77 |
| March 31, 2022 | 6.976 |
| December 31, 2021 | 1.492 |
| September 30, 2021 | 1.191 |
| June 30, 2021 | 1.117 |
| March 31, 2021 | 2.021 |
| December 31, 2020 | 1.467 |
| September 30, 2020 | 1.119 |
| June 30, 2020 | 0.9838 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.930 |
| December 31, 2019 | 1.517 |
| September 30, 2019 | 1.231 |
| June 30, 2019 | 1.034 |
| March 31, 2019 | 2.542 |
| December 31, 2018 | 1.52 |
| September 30, 2018 | 1.070 |
| June 30, 2018 | 0.8287 |
| March 31, 2018 | 0.6961 |
| December 31, 2017 | 0.1539 |
| September 30, 2017 | 0.1315 |
| June 30, 2017 | 0.6614 |
| March 31, 2017 | 0.4519 |
| December 31, 2016 | 0.3547 |
| September 30, 2016 | 0.1592 |
| June 30, 2016 | 0.0991 |
| March 31, 2016 | 0.0878 |
| December 31, 2015 | 0.0807 |
| September 30, 2015 | 0.0745 |
| June 30, 2015 | 0.0688 |
| March 31, 2015 | 0.1516 |
| December 31, 2014 | 0.1335 |
| September 30, 2014 | 0.0999 |
| June 30, 2014 | 0.1776 |
| March 31, 2014 | 0.1503 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| United Therapeutics Corp. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Biogen, Inc. | 0.4433 |
| Gilead Sciences, Inc. | 2.219 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.103B |
| Total Liabilities (Quarterly) | 1.345B |
| Shareholders Equity (Quarterly) | 757.49M |
| Current Ratio | 3.724 |
| Net Debt Paydown Yield | 0.48% |